Original language | English |
---|---|
Journal | JOURNAL OF CLINICAL ONCOLOGY |
Volume | 40 |
Issue number | 16 |
Publication status | Published - 2022 |
Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7) with high rate of signet cell component: Final results of the multicenter, randomized phase II/III trial of the German AIO and Italian GOIM.
TO Goetze, RD Hofheinz, H Schmalenberg, D Strumberg, E Goekkurt, S Angermeier, T Zander, J Potenberg, HG Kopp, D Pink, Gabriele Siegler, M Schenk, F De Vita, E Maiello, T Gaiser, D Sookthai, T Brulin, C Pauligk, N Homann, SE Al-Batran
Research output: Contribution to journal › Abstract (Journal) › peer-review
2
Citations
(Web of Science)